Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Lymphangioma
- Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
- Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations
- A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations
- Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies
- Weekly Sirolimus Therapy
- First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations
- TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN
- Topical Sirolimus in Cutaneous Lymphatic Malformations
- OK432 (Picibanil) in the Treatment of Lymphatic Malformations
- Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations
- Sildenafil for the Treatment of Lymphatic Malformations
- A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
- Selenium in the Treatment of Complicated Lymphatic Malformations
- Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
- Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations